- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HP-10-0006578

Mediere Pharmaceuticals Private Limited
About Mediere Pharmaceuticals Private Limited
Data last updated:
Mediere Pharmaceuticals Private Limited is a private limited company based in Nahan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 April 2023.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U21002HP2023PTC010020. Its GSTIN is 02AAQCM7690F1Z6 (Himachal Pradesh).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Abhinav Kansal and Manish Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nahan, Himachal Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.1 Cr. For the same year it recorded a net loss of ₹47.4 Lakh (net margin -22.6%) and EBITDA of -₹45.34 Lakh (EBITDA margin -21.6%).
The company is associated with 1 brand: Mediere.
Mediere Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-10-0006578).
Company details
Recognitions & Rankings of Mediere Pharmaceuticals
Contact details
Mediere Pharmaceuticals Private Limited's registered office is in Nahan, Himachal Pradesh.
- Registered AddressBasement No. 1, Hall B Hotel Natraj Classic, Nahan, Himachal Pradesh, India – 173030
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mediere Pharmaceuticals operates one associated brand: Mediere. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| mediere.in |
Business activity
The main business activity of Mediere Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mediere Pharmaceuticals Private Limited, buy the company report.
Financials of Mediere Pharmaceuticals Private Limited
FY 2025 filings availableMediere Pharmaceuticals Private Limited reported revenue of ₹2.1 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹45.34 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹47.4 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | -21.6% |
| Net Profit Margin | -22.6% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Mediere Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mediere Pharmaceuticals Private Limited
Mediere Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhinav Kansal Also directs: Prime Fabtech Private Limited, HP India Metal Private Limited, Charvik Quantum LLP and 1 more | Director | 20 Apr 2023 | 3 Years 6 Months | Current |
| Manish Gupta Also directs: Amrit Fabtech Private Limited, Prime Fabtech Private Limited, HP India Metal Private Limited and 1 more | Director | 20 Apr 2023 | 3 Years 6 Months | Current |
| Tejas Kansal Also directs: Apotekare Lifesciences Private Limited | Director | 20 Apr 2023 | 3 Years 6 Months | Current |
| Kapil Kansal Also directs: HP India Metal Private Limited | Director | 20 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Mediere Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glalet Pharmaceuticals Private Limited | ₹2.1 Cr (FY 2024) | 552.0% | Lucknow, Uttar Pradesh, India | |||
| Bhardwaj India Private Limited | ₹2.1 Cr (FY 2019) | 143.0% | New Delhi, Delhi, India | |||
| Mediere Pharmaceuticals Private Limitedthis company | ₹2.1 Cr (FY 2024) | -₹47.4 Lakh | -22.6% | Nahan, Himachal Pradesh, India | ||
| Spycaa Life Care Sciences Private Limited | ₹2.1 Cr (FY 2024) | 14.0% | Maduranthakam, Tamil Nadu, India |
To see the full peer comparison of Mediere Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mediere Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediere Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mediere Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAQCM7690F1Z6 | Himachal Pradesh | Active | 01 May 2023 |
To see the full GST registrations and return filing status of Mediere Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mediere Pharmaceuticals Private Limited has 9 board changes on record since 2023: 8 appointments and 1 cessation. The latest: Devendra Sharma ceased to be Additional Director on 07 Apr 2025.
Frequently asked questions
Mediere Pharmaceuticals is an active private limited company based in Nahan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 April 2023 (3+ years old) and is registered under CIN U21002HP2023PTC010020.
Mediere Pharmaceuticals has 4 current directors:
- Abhinav Kansal - Director
- Manish Gupta - Director
- Tejas Kansal - Director
- Kapil Kansal - Director
The latest financial statements of Mediere Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Mediere Pharmaceuticals is 02AAQCM7690F1Z6, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Mediere Pharmaceuticals is U21002HP2023PTC010020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediere Pharmaceuticals was incorporated on 20 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Mediere Pharmaceuticals by revenue are Glalet Pharmaceuticals Private Limited, Bhardwaj India Private Limited, Spycaa Life Care Sciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Devendra Sharma ceased to be Additional Director on 07 Apr 2025. Devendra Sharma was appointed as Additional Director on 15 May 2024. Abhinav Kansal was appointed as Director on 20 Apr 2023. Mediere Pharmaceuticals has 9 board changes on record in total.
Yes, Mediere Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-10-0006578).
The registered office of Mediere Pharmaceuticals is at Basement No. 1, Hall B Hotel Natraj Classic, Nahan, Himachal Pradesh, India – 173030.
Mediere Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

